quinic acid has been researched along with Encephalopathy, Toxic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, G; Gao, H; Jiang, X; Li, X; Liu, W; Ren, T; Shen, Z; Xu, Z; Yang, Y; Zhao, Q | 1 |
| Chung, IM; Kim, MY; Moon, HI; Park, WH | 1 |
2 other study(ies) available for quinic acid and Encephalopathy, Toxic
| Article | Year |
|---|---|
DCMQA, a caffeoylquinic acid derivative alleviates NMDA-induced neurotoxicity via modulating GluN2A and GluN2B-containing NMDA receptors in vitro.
Topics: Apoptosis; Calcium; Cell Line, Tumor; Cell Survival; Humans; L-Lactate Dehydrogenase; Membrane Potential, Mitochondrial; N-Methylaspartate; Neuroprotective Agents; Neurotoxicity Syndromes; Quinic Acid; Receptors, N-Methyl-D-Aspartate | 2020 |
Quinic acid derivatives from Saussurea triangulata attenuates glutamate-induced neurotoxicity in primary cultured rat cortical cells.
Topics: Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Glutamic Acid; Neuroprotective Agents; Neurotoxicity Syndromes; Quinic Acid; Rats; Saussurea | 2009 |